Lumen Bioscience a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced it was awarded $16.2 million by the U.S. Department of Defense...
Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced clinical development progress for LMN-201, an investigational orally delivered cocktail...
